Research Summary
AI-generated summary of this SEC filing
Anixa (ANIX) CEO Amit Kumar Buys 5,000 Shares
What Happened
Amit Kumar, CEO of Anixa Biosciences (ANIX), reported an open-market purchase of 5,000 shares on July 31, 2026. The shares were acquired at $3.47 per share for a total transaction value of $17,350. This was a purchase (code P), which investors often view as a more informative signal than routine sales, though it does not by itself indicate the insider’s motivations.
Key Details
- Transaction date: 2026-07-31
- Transaction type/code: Open-market purchase (P)
- Price per share: $3.47
- Shares acquired: 5,000
- Total value: $17,350
- Shares owned after transaction: Not specified in the provided filing details
- Footnotes / plan info: No 10b5-1 plan, tax-withholding, or other footnotes were indicated in the information supplied
- Filing date: 2026-08-03 — the Form 4 was filed after the trade; this appears to be within the typical 2-business-day reporting window for Form 4s
Context
Purchases by executives can be interpreted as a vote of confidence, but they should be considered alongside other information (company fundamentals, recent filings, and the insider’s overall trading pattern). This report documents a straightforward open-market acquisition; no option exercises, gifts, or cashless sales were reported in the disclosed transaction.